1. Corrigendum to "Efficacy of continued vedolizumab therapy in patients with Crohn's disease who did not respond to vedolizumab induction therapy at week 6": [J Crohns Colitis 8S1 (2014) P497 S274-5]. (1st October 2014) Authors: Sandborn, W.J.; Feagan, B.; Reinisch, W.; Smyth, M.; Xu, J.; Parikh, A.; Fox, I. Journal: Journal of Crohn's and colitis Issue: Volume 8:Number 10(2014:Oct.) Page Start: 1337 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Editorial: aminosalicylates in Crohn's disease—prevalence, risks, costs and time to reassess? Authors' reply. Issue 4 (24th July 2018) Authors: Jairath, V.; Ma, C.; Feagan, B. Journal: Alimentary pharmacology & therapeutics Issue: Volume 48:Issue 4(2018) Page Start: 489 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Effects of concomitant immunomodulators on the pharmacokinetics, efficacy and safety of adalimumab in patients with Crohn's disease or ulcerative colitis who had failed conventional therapy. Issue 1 (7th November 2016) Authors: Colombel, J.‐F.; Jharap, B.; Sandborn, W. J.; Feagan, B.; Peyrin‐Biroulet, L.; Eichner, S. F.; Robinson, A. M.; Mostafa, N. M.; Zhou, Q.; Thakkar, R. B. Journal: Alimentary pharmacology & therapeutics Issue: Volume 45:Issue 1(2017) Page Start: 50 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Review article: moving towards common therapeutic goals in Crohn's disease and rheumatoid arthritis. Issue 8 (1st March 2017) Authors: Allen, P. B.; Olivera, P.; Emery, P.; Moulin, D.; Jouzeau, J.‐Y.; Netter, P.; Danese, S.; Feagan, B.; Sandborn, W. J.; Peyrin‐Biroulet, L. Journal: Alimentary pharmacology & therapeutics Issue: Volume 45:Issue 8(2017) Page Start: 1058 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗